Investor Presentaiton

Contents ■ Executive Summary ■ Market & Strategic Positioning Biopharma Testing Services Food Testing Environment Testing Clinical Diagnostics Other ■Financial review ■ ESG ■ Outlook ■ Summarised Financial Statements ■ Appendix 449 64 eurofins

View entire presentation